These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24178970)

  • 21. Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults.
    Lee H; Yi SH; Seo MS; Hyun JN; Jeon JS; Noh H; Han DC; Hwang SD; Jin SY; Kwon SH
    Korean J Intern Med; 2012 Sep; 27(3):293-300. PubMed ID: 23019394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a prediction score system in lupus nephritis.
    Tang Y; Qin W; Peng W; Tao Y
    Medicine (Baltimore); 2017 Sep; 96(37):e8024. PubMed ID: 28906386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of immunosuppression in IgA nephropathy based on the oxford classification.
    Palamuthusingam D; Castledine C; Lawman S
    Saudi J Kidney Dis Transpl; 2018; 29(2):341-350. PubMed ID: 29657202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
    Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External Validation of the International IgA Nephropathy Prediction Tool.
    Zhang J; Huang B; Liu Z; Wang X; Xie M; Guo R; Wang Y; Yu D; Wang P; Zhu Y; Ren J
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1112-1120. PubMed ID: 32616496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes and predictors for ESRD and mortality in primary GN.
    Chou YH; Lien YC; Hu FC; Lin WC; Kao CC; Lai CF; Chiang WC; Lin SL; Tsai TJ; Wu KD; Chen YM
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1401-8. PubMed ID: 22798538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
    Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
    Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.
    Le W; Zeng CH; Liu Z; Liu D; Yang Q; Lin RX; Xia ZK; Fan ZM; Zhu G; Wu Y; Xu H; Zhai Y; Ding Y; Yang X; Liang S; Chen H; Xu F; Huang Q; Shen H; Wang J; Fogo AB; Liu ZH
    BMC Nephrol; 2012 Nov; 13():158. PubMed ID: 23181565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study.
    Wang Z; Zhou X; Shi S; Liu L; Lv J; Zhang H
    Am J Nephrol; 2024; 55(5):529-538. PubMed ID: 39074466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
    Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy.
    Miyabe Y; Karasawa K; Akiyama K; Ogura S; Takabe T; Sugiura N; Seki M; Iwabuchi Y; Hanafusa N; Uchida K; Nitta K; Moriyama T
    Sci Rep; 2021 Feb; 11(1):3584. PubMed ID: 33574388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
    Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.